Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey
about
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and TherapyPleiotropy analysis of quantitative traits at gene level by multivariate functional linear modelsPrevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study.Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study.Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methodsDiagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.The effect of berberis vulgaris extract on transaminase activities in non-alcoholic Fatty liver disease.Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in miceMulticausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns StudyCorrelation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease.Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS).Review article: the endocannabinoid system in liver disease, a potential therapeutic target.Fatty liver score and 15-year incidence of type 2 diabetes.Fatty liver and serum cholinesterase are independently correlated with HbA1c levels: cross-sectional analysis of 5384 people.Hepatorenal repercussions of alcoholic exposure in a rat model: a dose-dependent study of metformin intervention.Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study.How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.Nonalcoholic Fatty Liver Disease in University Rugby Football Players.Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study.
P2860
Q28068137-581A957A-FD37-4D02-9E94-A529A179431DQ28647065-CFCD0425-4DE6-4BF9-907A-A73CD522BC99Q33832177-BB64277A-FC62-4E07-8F2E-C91D743B1FFEQ33886948-C711ED3A-BAB0-4C5D-A0AC-A190E75BFF74Q33905587-1E12DB84-8408-4B75-8181-9035E822052AQ34093727-5A08AB53-C0CD-4EB3-AE89-DDAEB49DF525Q34653992-EE8DDEB4-E05B-4F1A-AF5E-DCE5485E2778Q34746071-ABDB8093-724A-443C-95F9-920A7383AFD6Q35018573-8DA37F9A-45F7-43C3-8922-720E484AC4ADQ35149311-1F25F243-49DF-4A4B-9473-21AD063C27D5Q35700655-974239C1-7501-4764-8A4E-3D8CC877479FQ36105525-C7896E2D-CFFD-46D6-AD7A-C6B6A4DA59B4Q36267994-BE88592F-F4A6-45D1-983C-F2549CAA005DQ37472354-767F8434-4CFB-4C9B-BEFF-0CD45E846BD2Q37660758-7FE49615-3139-4F14-8527-5484B84933E8Q38052856-352DFE2E-5BD4-4613-8692-3EC9D2EEAE1DQ38194626-9E4989F5-08CB-4752-ACF2-504BF7AEBF10Q40707205-E10BF317-1BDC-4F15-A238-C7096083D30AQ42233730-443E4DB0-1E81-453A-BBA6-7DC947BE6CC3Q43226090-05B1BE1E-731D-4881-ADF3-6E22673387FEQ44123228-5A02FFD3-F4C5-4104-8116-40EE6FBA8840Q47429375-4FA56387-FAA5-48AF-BD6F-0F2F597FCEA0Q48062300-C0DCA33F-35C8-40DB-96A8-C81C15ED3F81Q55512582-8768A2AD-98D5-421C-8A24-04C9619E9C85Q55647258-5FBDFC64-965B-4AD9-ADF0-7935B26A067B
P2860
Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@ast
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@en
Non-alcoholic and alcoholic fa ...... diabetes: the FIN-D2D survey.
@nl
type
label
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@ast
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@en
Non-alcoholic and alcoholic fa ...... diabetes: the FIN-D2D survey.
@nl
prefLabel
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@ast
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@en
Non-alcoholic and alcoholic fa ...... diabetes: the FIN-D2D survey.
@nl
P2093
P2860
P50
P356
P1433
P1476
Non-alcoholic and alcoholic fa ...... 2 diabetes: the FIN-D2D survey
@en
P2093
Anna Kotronen
Heikki Oksa
Jouko Sundvall
Juha Saltevo
Liisa Saarikoski
Timo Saaristo
P2860
P2888
P356
10.1186/1471-2458-10-237
P407
P577
2010-05-10T00:00:00Z
P5875
P6179
1053530625